BRIM Biotechnology Profit Margin

The latest profit margin for 6885.TW is -11423.48% as of December 2025. That compares with -140918.83% in the prior-year period — up 91.9% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside BRIM Biotechnology's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6885.TW's profit margin moved from -140918.83% to -11423.48% — a 91.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BRIM Biotechnology's valuation or profitability profile.

Against Healthcare companies, 6885.TW currently prints -11423.48% for profit margin, while the sector average sits near 9.48%. That is roughly 120588.7% below the sector mean. Large gaps often invite a closer look at BRIM Biotechnology's growth, margins, and balance sheet.

Profit Margin shows how effectively BRIM Biotechnology converts resources into returns. At -11423.48%, 6885.TW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -140918.83% in the prior-year period — up 91.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 6885.TW's profit margin (-11423.48%), review year-over-year change from -140918.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.